Results 141 to 150 of about 1,156,270 (203)

Safety of synthetic cannabidiol as a novel food pursuant to regulation (EU) 2015/2283

EFSA Journal, Volume 24, Issue 9, September 2026.
Abstract Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on cannabidiol (CBD) obtained by chemical synthesis as a novel food (NF) pursuant to Regulation (EU) 2015/2283.
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Dominique Turck, Torsten Bohn, Montaña Cámara, Jacqueline Castenmiller, Stefaan De Henauw, Ángeles Jos, Alexandre Maciuk, Inge Mangelsdorf, Breige McNulty, Androniki Naska, Kristina Pentieva, Alfonso Siani, Frank Thies, Francesco Cubadda, Harry J. McArdle, Viviana Trezza, Océane Albert, Elisa Beneventi, Marcello Laganaro, Irene Nuin Garciarena, Annamaria Rossi, Sebastián Berrío Cruz, Francesca Seminati, Maura Magani, Karen Ildico Hirsch‐Ernst   +26 more
wiley   +1 more source

Compounded Complexity: The Impact of Social Determinants of Health on a Child With Cerebral Palsy and Lennox-Gastaut Syndrome. [PDF]

Cureus
Caldes N, Perez NM, Quintero J, Semidey K.   +3 more
europepmc   +1 more source

Long-term follow-up in patients with Lennox-Gastaut syndrome. Epileptological aspects, psychomotor development and social adaptation

, 1991
In 1989/90 a follow-up was made possible on 72 of 78 patients who have been treated for the supposed or confirmed diagnosis of a Lennox-Gastaut-Syndrome at the university children hospital of Berne between 1964 and 1978.
Blatter Arifi, Verena
core  

Safety of cannabidiol isolated from Cannabis sativa L. as a novel food pursuant to Regulation (EU) 2015/2283

EFSA Journal, Volume 24, Issue 9, September 2026.
Abstract Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on cannabidiol (CBD) isolated from Cannabis sativa L. as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF consists of ≥ 98% w/w CBD.
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Dominique Turck, Torsten Bohn, Montaña Cámara, Jacqueline Castenmiller, Stefaan De Henauw, Ángeles Jos, Alexandre Maciuk, Inge Mangelsdorf, Breige McNulty, Androniki Naska, Kristina Pentieva, Alfonso Siani, Frank Thies, Francesco Cubadda, Harry J. McArdle, Viviana Trezza, Océane Albert, Elisa Beneventi, Marcello Laganaro, Irene Nuin Garciarena, Annamaria Rossi, Sebastián Berrío Cruz, Francesca Seminati, Maura Magani, Karen Ildico Hirsch‐Ernst   +26 more
wiley   +1 more source

Safety of Cannabis sativa L. extract as a novel food pursuant to Regulation (EU) 2015/2283

EFSA Journal, Volume 24, Issue 9, September 2026.
Abstract Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on Cannabis sativa L. extract as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF consists of 57%–65% w/w cannabidiol (CBD) and 9%–17% w/w of other cannabinoids.
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Dominique Turck, Torsten Bohn, Montaña Cámara, Jacqueline Castenmiller, Stefaan De Henauw, Ángeles Jos, Alexandre Maciuk, Inge Mangelsdorf, Breige McNulty, Androniki Naska, Kristina Pentieva, Alfonso Siani, Frank Thies, Francesco Cubadda, Harry J. McArdle, Viviana Trezza, Océane Albert, Elisa Beneventi, Marcello Laganaro, Irene Nuin Garciarena, Annamaria Rossi, Sebastián Berrío Cruz, Francesca Seminati, Maura Magani, Karen Ildico Hirsch‐Ernst   +26 more
wiley   +1 more source

Beyond seizures: A multidimensional approach to non-seizure issues in Lennox-Gastaut syndrome. Insights from Italian experts. [PDF]

Epilepsia Open
Di Gennaro G, Battaglia DI, Bonanni P, Duma GM, Coppola A, Ferlazzo E, Pruna D, Di Bonaventura C.   +7 more
europepmc   +1 more source

Urgent completion corpus callosotomy for severe behavioral deterioration associated with seizure exacerbation in adult Lennox-Gastaut syndrome. [PDF]

Epileptic Disord
Uchida D, Baba S, Arai R, Uotani S, Shirahama M, Takeuchi M, Ogawa Y, Matsuo A, Matsunaga Y, Maeda H, Ujifuku K, Hiu T, Yoshida K, Baba H, Matsuo T.   +14 more
europepmc   +1 more source

No Evidence for an Association Between DIP2B Repeat Expansion and Neurological Disease

Movement Disorders, Volume 41, Issue 9, Page 2529-2531, September 2026.
Chia‐Ying Ko, Leon Schütz, Thomas Braun, Elena Buena‐Atienza, Nicolas Casadei, Danique Beijer, Ludger Schöls, Tobias B. Haack, Stephan Ossowski, Holger Hengel   +9 more
wiley   +1 more source

Cannabidiol reduces atypical absence seizures and epileptic spasms in a Gabrb3^+/D120N mouse model of Lennox-Gastaut syndrome. [PDF]

Epilepsia Open
Harman T, Sharman LA, Yip KL, Bedoya-Pérez M, Janve V, Arnold JC.   +5 more
europepmc   +1 more source

A temporary spike: Investigating Lennox-Gastaut syndrome incidence in the US following FDA approval of cannabidiol. [PDF]

Epileptic Disord
Marcinski Nascimento KJ, Li Y, Lin BY, Dixon-Salazar T, Perry MS, Xu KY, Nascimento FA.   +6 more
europepmc   +1 more source